Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion
- PMID: 21896698
- PMCID: PMC3193112
- DOI: 10.1503/cmaj.110454
Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion
Abstract
Background: The association between the use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy and the risk of spontaneous abortion remains unclear because of inconsistent research results and the lack of evidence for an effect due to specific types or dosages of nonaspirin NSAIDs. We aimed to quantify the association between having a spontaneous abortion and types and dosages of nonaspirin NSAIDs in a cohort of pregnant women.
Methods: Using a nested case-control design, we obtained data from the Quebec Pregnancy Registry for 4705 women who had a spontaneous abortion. For each instance, we randomly selected 10 controls from the remaining women in the registry who were matched by index date (date of the spontaneous abortion) and gestational age. Use of nonaspirin NSAIDs (identified by filled prescriptions) and nonuse were compared. We also looked for associations between different types and dosages of nonaspirin NSAIDs and having a spontaneous abortion. Analyses of associations and adjustment for confounding were done using conditional logistic regression.
Results: We identified 4705 cases of spontaneous abortion (352 exposed [7.5%]); 47 050 controls (1213 exposed [2.6%]). Adjusting for potential confounders, the use of nonaspirin NSAIDs during pregnancy was significantly associated with the risk of spontaneous abortion (odds ratio [OR] 2.43, 95% confidence interval [CI] 2.12-2.79). Specifically, use of diclofenac (OR 3.09, 95% CI 1.96-4.87), naproxen (OR 2.64, 95% CI 2.13-3.28), celecoxib (OR 2.21, 95% CI 1.42-3.45), ibuprofen (OR 2.19, 95% CI 1.61-2.96) and rofecoxib (OR 1.83, 95% CI 1.24-2.70) alone, and combinations thereof (OR 2.64, 95% CI 1.59-4.39), were all associated with increased risk of spontaneous abortion. No dose-response effect was seen.
Interpretation: Gestational exposure to any type or dosage of nonaspirin NSAIDs may increase the risk of spontaneous abortion. These drugs should be used with caution during pregnancy.
Comment in
-
Spontaneous abortion and NSAIDs.CMAJ. 2011 Dec 13;183(18):2145; author reply 2145-6. doi: 10.1503/cmaj.111-2092. CMAJ. 2011. PMID: 22159358 Free PMC article. No abstract available.
-
Use of non-aspirin NSAIDs during pregnancy may increase the risk of spontaneous abortion.Evid Based Nurs. 2012 Jul;15(3):76-7. doi: 10.1136/ebnurs-2011-100439. Epub 2012 Mar 12. Evid Based Nurs. 2012. PMID: 22411163 No abstract available.
-
Nicht-steroidale Analgetika erhöhen das Risiko für Spontanabort.Praxis (Bern 1994). 2012 May 9;101(10):677-8. doi: 10.1024/1661-8157/a000934. Praxis (Bern 1994). 2012. PMID: 22565561 German. No abstract available.
Similar articles
-
Use of antidepressants during pregnancy and the risk of spontaneous abortion.CMAJ. 2010 Jul 13;182(10):1031-7. doi: 10.1503/cmaj.091208. Epub 2010 May 31. CMAJ. 2010. PMID: 20513781 Free PMC article.
-
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.Arch Intern Med. 2005 May 9;165(9):978-84. doi: 10.1001/archinte.165.9.978. Arch Intern Med. 2005. PMID: 15883235
-
Use of antibiotics during pregnancy and risk of spontaneous abortion.CMAJ. 2017 May 1;189(17):E625-E633. doi: 10.1503/cmaj.161020. CMAJ. 2017. PMID: 28461374 Free PMC article.
-
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.Stroke. 2016 Feb;47(2):356-64. doi: 10.1161/STROKEAHA.115.011678. Epub 2015 Dec 15. Stroke. 2016. PMID: 26670086 Review.
-
Pregnancy outcomes and birth defects in offspring following Non-steroidal anti-inflammatory drugs exposure during pregnancy: A systematic review and meta-analysis.Reprod Toxicol. 2024 Apr;125:108561. doi: 10.1016/j.reprotox.2024.108561. Epub 2024 Feb 27. Reprod Toxicol. 2024. PMID: 38423229 Review.
Cited by
-
Diabetes Mellitus and Gynecological and Inflammation Disorders Increased the Risk of Pregnancy Loss in a Population Study.Life (Basel). 2024 Jul 19;14(7):903. doi: 10.3390/life14070903. Life (Basel). 2024. PMID: 39063657 Free PMC article.
-
Lupus nephritis: management challenges during pregnancy.Front Nephrol. 2024 Jun 4;4:1390783. doi: 10.3389/fneph.2024.1390783. eCollection 2024. Front Nephrol. 2024. PMID: 38895665 Free PMC article. Review.
-
Perioperative management of surgical procedure during pregnancy: a systematic review.Ann Med Surg (Lond). 2024 Apr 16;86(6):3432-3441. doi: 10.1097/MS9.0000000000002057. eCollection 2024 Jun. Ann Med Surg (Lond). 2024. PMID: 38846888 Free PMC article.
-
News in pharmacology for the main medical pathologies of gestation.Front Pharmacol. 2024 Jan 4;14:1240032. doi: 10.3389/fphar.2023.1240032. eCollection 2023. Front Pharmacol. 2024. PMID: 38239189 Free PMC article. Review.
-
The effects of obesity and insulin dysregulation on mare reproduction, pregnancy, and foal health: a review.Front Vet Sci. 2023 Apr 20;10:1180622. doi: 10.3389/fvets.2023.1180622. eCollection 2023. Front Vet Sci. 2023. PMID: 37152686 Free PMC article. Review.
References
-
- Ofori B, Oraichi D, Blais L, et al. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: anested case–control study. Birth Defects Res B Dev Reprod Toxicol 2006;77:268–79 - PubMed
-
- Olesen C, Steffensen FH, Nielsen GL, et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol 1999; 55:139–44 - PubMed
-
- Nakhai-Pour HR, Bérard A. Major malformations after first trimester exposure to aspirin and NSAIDs. Expert Review 2008; 1:605–16 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical